In triple-negative breast cancer cells, BBR reduces interleukin-8 (IL-8) expression by blocking the EGFR/MEK/ERK signaling pathway to prevent cell invasion and metastasis (Kim et al., 2018). The gene discussed is EGFR; the disease is triple-negative breast carcinoma.